Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2021 · 10-Q
Revenue$2.33B$2.33B+9.6% vs Q1 2020 Net Income$69.59M$69.59MN/M vs Q1 2020 EPS Diluted$0.98$0.98N/M vs Q1 2020 Gross Profit$442,751,000+64.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow$25,423,000−72.8% Free Cash Flowderived$20,375,000−77.0% Margins · derivedGross margin19.0%+6.4 pt vs Q1 2020
Operating margin6.3%+5.8 pt vs Q1 2020
Net margin3.0%+3.5 pt vs Q1 2020
ended Mar 31, 2021 · filed May 5, 2021 · 35 d after period end